Legal analysis: I: volume for price: to give enterprises the commitment of market sales to carry out volume for price, price for volume.
Two: the recruitment and procurement of one: since recruited to ensure that the terminal hospitals on the amount of product use.
Three: quality and quantity: in order to meet the accessibility of the public medication and quality assurance, pharmaceutical companies must ensure the quality and production.
Four: Guaranteed Payback: Medical institutions have to settle with enterprises in a timely manner according to the contract to reduce the transaction costs of enterprises. And in order to ease the financial pressure on medical institutions, health insurance will pay at least 30% of the advance payment to medical institutions.
Legal basis: "State Organization Pilot Program for Centralized Purchase and Use of Drugs" Article 3 Specific Measures
(a) Banded purchasing, volume for price. On the basis of the purchasing volume reported by the public medical institutions in the pilot areas, the total purchasing volume is estimated at 60%-70% of the total annual drug usage of all public medical institutions in the pilot areas, and the purchasing is carried out in a banded manner, with the volume and price linked and the price exchanged for the volume, so as to form the centralized purchasing price of the drugs, and the public medical institutions in the pilot cities, or their representatives, will sign banded purchasing and sales contracts with the manufacturers according to the above purchasing price. The public medical institutions in the pilot cities or their representatives sign contracts with the manufacturers on the basis of the above procurement prices. The remaining quantity, the public medical institutions can still purchase the provincial centralized procurement of drugs, other price appropriate varieties of the grid.
(2) Tendering and procurement to ensure the use. Through bidding, bargaining, negotiation and other forms of centralized purchasing varieties, public medical institutions in the pilot area should be given priority to use, to ensure that the contracted amount is completed within one year.
(3) to ensure quality and supply. To strictly implement the quality shortlisting standards and supply shortlisting standards, effectively prevent the only low price without regard to the quality of the winning bid, and strengthen the whole chain of quality supervision of the production, circulation and use of selected drugs. Under this premise, a system of investigation, evaluation, assessment and monitoring of the quality and supply capacity of the shortlisted enterprises will be established. Producers independently select business enterprises with distribution capacity and good credibility to distribute centrally purchased varieties, and establish a system of emergency reserves, stockpiling and reporting of production stoppages by producers in accordance with the purchase and sales contracts. When there is a failure to supply according to the contract, can not guarantee the quality and supply, etc., to take compensation, discipline, withdrawal, alternative and emergency safeguard measures accordingly, to ensure the quality and supply of medicines.
(D) to ensure payment back, reduce transaction costs. Medical institutions as the first responsibility for the settlement of drug payments, should be in accordance with the provisions of the contract with the enterprise timely settlement, reduce the transaction costs of enterprises. Strictly investigate the medical institutions do not settle drug payments on time. On the basis of the total budget, the medical insurance fund will pay no less than 30% of the purchasing amount in advance to the medical institutions. Conditional cities can pilot direct settlement of medical insurance.